Skip to main content

Table 3 Cumulative cost effectiveness/savings after 5, 10, 25, and 50 years of vaccination program. Cost savings is achieved within 6 years considering indirect costs and within 8 years if indirect costs are excluded. Values are for the entire population

From: Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach

Cumulative outcomes

Universal Vaccination

5 y

10 y

25 y

50 y

QALY’s Gaineda

4800

10,521

24,144

37,502

Vaccination Cost (millions)

$9.40

$17.52

$35.76

$52.83

Disease Cost Avoided (millions)

$8.06

$18.60

$47.78

$81.41

Indirect cost avoided (millions)

$0.99

$2.61

$8.00

$14.03

Total Cost Savings(millions, including indirect costs)

$3.69

$20.03

$42.60

Total Cost Savings(millions, excluding indirect cost)

$1.09

$12.02

$28.57

ICERb ($/QALY, including indirect costs)

75

Cost saving

Cost saving

Cost saving

ICER ($/QALY, excluding indirect cost)

281

Cost saving

Cost saving

Cost saving

  1. aQALY, quality-adjusted life-year
  2. bICER, incremental cost-effectiveness ratio